Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18) F-FDOPA PET: focus on missed lesions
Autor: | Arnaud Deveze, David Taïeb, Isabelle Morange, Clara C. Chen, Elise M. Blanchet, Sophie Gabriel, Frederic Sebag, Anne Barlier, Nicolas Fakhry, Karel Pacak |
---|---|
Přispěvatelé: | Service de chirurgie générale et endocrinienne, Hôpital de la Timone [CHU - APHM] (TIMONE), Laboratoire de Biomécanique Appliquée (LBA UMR T24), Aix Marseille Université (AMU)-Université Gustave Eiffel, Centre de recherche en neurobiologie - neurophysiologie de Marseille (CRN2M), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS) |
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
medicine.medical_specialty
MESH: Paraganglioma Endocrinology Diabetes and Metabolism Adrenal Gland Neoplasm Adrenal Gland Neoplasms Pheochromocytoma MESH: Dihydroxyphenylalanine Article 030218 nuclear medicine & medical imaging Paraganglioma Lesion 03 medical and health sciences 0302 clinical medicine Endocrinology Germline mutation Internal medicine Humans Medicine Abdominal Neoplasms MESH: Pheochromocytoma [SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry Molecular Biology/Biochemistry [q-bio.BM] False Negative Reactions Retrospective Studies MESH: False Negative Reactions MESH: Humans medicine.diagnostic_test business.industry Retrospective cohort study MESH: Retrospective Studies MESH: Abdominal Neoplasms medicine.disease MESH: Adrenal Gland Neoplasms MESH: Succinate Dehydrogenase MESH: Positron-Emission Tomography Dihydroxyphenylalanine 3. Good health Succinate Dehydrogenase MESH: Head and Neck Neoplasms Head and Neck Neoplasms Positron emission tomography Positron-Emission Tomography 030220 oncology & carcinogenesis medicine.symptom business |
Zdroj: | Clinical Endocrinology Clinical Endocrinology, Wiley, 2013, 79 (2), pp.170-7. ⟨10.1111/cen.12126⟩ Clinical Endocrinology, 2013, 79 (2), pp.170-7. ⟨10.1111/cen.12126⟩ |
ISSN: | 0300-0664 1365-2265 |
DOI: | 10.1111/cen.12126⟩ |
Popis: | International audience; AIMS AND METHODS: To evaluate the clinical value of (18) F-fluorodihydroxyphenylalanine ((18) F-FDOPA) PET in relation to tumour localization and the patient's genetic status in a large series of pheochromocytoma/paraganglioma (PHEO/PGL) patients and to discuss in detail false-negative results. A retrospective study of PGL patients who were investigated with (18) F-FDOPA PET or PET/CT imaging in two academic endocrine tumour centres was conducted (La Timone University Hospital, Marseilles, France and National Institutes of Health (NIH), Bethesda, MD, USA). RESULTS: One hundred sixteen patients (39*7% harbouring germline mutations in known disease susceptibility genes) were evaluated for a total of 195 PHEO/PGL foci. (18) F-FDOPA PET correctly detected 179 lesions (91*8%) in 107 patients (92*2%). Lesion-based sensitivities for parasympathetic PGLs (head, neck, or anterior/middle thoracic ones), PHEOs, and extra-adrenal sympathetic (abdominal or posterior thoracic) PGLs were 98*2% [96*5% for Timone and 100% for NIH], 93*9% [93*8 and 93*9%] and 70*3% [47*1 and 90%] respectively (P < 0*001). Sympathetic (adrenal and extra-adrenal) SDHx-related PGLs were at a higher risk for negative (18) F-FDOPA PET than non-SDHx-related PGLs (14/24 vs 0/62, respectively, P < 0*001). In contrast, the risk of negative (18) F-FDOPA PET was lower for parasympathetic PGLs regardless of the genetic background (1/90 in SDHx vs 1/19 in non-SDHx tumours, P = 0*32). (18) F-FDOPA PET failed to detect two head and neck PGLs (HNPGL), likely due to their small size, whereas most missed sympathetic PGL were larger and may have exhibited a specific (18) F-FDOPA-negative imaging phenotype. (18) F-FDG PET detected all the missed sympathetic lesions. CONCLUSIONS: (18) F-FDOPA PET appears to be a very sensitive functional imaging tool for HNPGL regardless of the genetic status of the tumours. Patients with false-negative tumours on (18) F-FDOPA PET should be tested for SDHx mutations. |
Databáze: | OpenAIRE |
Externí odkaz: |